These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 28854143

  • 21. Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.
    Goel V, Naylor CD.
    Can J Cardiol; 1992; 8(1):31-8. PubMed ID: 1617509
    [Abstract] [Full Text] [Related]

  • 22. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, Ohman EM, Barbash GI, Betriu A, Sadowski Z, Topol EJ, Califf RM.
    JAMA; 1996 Mar 13; 275(10):777-82. PubMed ID: 8598594
    [Abstract] [Full Text] [Related]

  • 23. Cost and quality of life: thrombolysis and primary angioplasty.
    Goldman L.
    J Am Coll Cardiol; 1995 Jun 13; 25(7 Suppl):38S-41S. PubMed ID: 7775713
    [Abstract] [Full Text] [Related]

  • 24. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
    Naylor CD, Bronskill S, Goel V.
    Can J Cardiol; 1993 Jun 13; 9(6):553-8. PubMed ID: 8221354
    [No Abstract] [Full Text] [Related]

  • 25. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W, Pierre K, Massel D.
    Can J Cardiol; 2005 Apr 13; 21(5):423-31. PubMed ID: 15861260
    [Abstract] [Full Text] [Related]

  • 26. [Socioeconomic implications of the practice of thrombolysis in the acute stage of myocardial infarction].
    Herve C, Castiel D, Gaillard M, Daussac C, Leroux V, Jan F, Castaigne A.
    Arch Mal Coeur Vaiss; 1989 Mar 13; 82(3):353-8. PubMed ID: 2502091
    [Abstract] [Full Text] [Related]

  • 27. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
    Berg J, Lindgren P, Spiesser J, Parry D, Jönsson B.
    Clin Ther; 2007 Jun 13; 29(6):1184-202. PubMed ID: 17692733
    [Abstract] [Full Text] [Related]

  • 28. Cost-effectiveness of thrombolytic therapy for acute myocardial infarction.
    Castillo PA, Palmer CS, Halpern MT, Hatziandreu EJ, Gersh BJ.
    Ann Pharmacother; 1997 May 13; 31(5):596-603. PubMed ID: 9161657
    [Abstract] [Full Text] [Related]

  • 29. Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria.
    Coyle D, Buxton MJ, O'Brien BJ.
    Health Econ; 2003 May 13; 12(5):421-7. PubMed ID: 12720259
    [Abstract] [Full Text] [Related]

  • 30. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP, Busija L, Liew D, Teo S, Davis SM, Yan B.
    Stroke; 2013 Aug 13; 44(8):2269-74. PubMed ID: 23780955
    [Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness of captopril therapy after myocardial infarction.
    Tsevat J, Duke D, Goldman L, Pfeffer MA, Lamas GA, Soukup JR, Kuntz KM, Lee TH.
    J Am Coll Cardiol; 1995 Oct 13; 26(4):914-9. PubMed ID: 7560617
    [Abstract] [Full Text] [Related]

  • 32. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial.
    Aasa M, Henriksson M, Dellborg M, Grip L, Herlitz J, Levin LA, Svensson L, Janzon M.
    Am Heart J; 2010 Aug 13; 160(2):322-8. PubMed ID: 20691839
    [Abstract] [Full Text] [Related]

  • 33. Medical decision making in the choice of a thrombolytic agent for acute myocardial infarction. Quebec Acute Coronary Care Working Group.
    Brophy JM, Joseph L, Theroux P.
    Med Decis Making; 1999 Aug 13; 19(4):411-8. PubMed ID: 10520679
    [Abstract] [Full Text] [Related]

  • 34. Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis.
    Earnshaw SR, Jackson D, Farkouh R, Schwamm L.
    Stroke; 2009 May 13; 40(5):1710-20. PubMed ID: 19286581
    [Abstract] [Full Text] [Related]

  • 35. Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase.
    Massel D.
    Can J Cardiol; 1999 Feb 13; 15(2):173-9. PubMed ID: 10079776
    [Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction.
    Selmer R, Halvorsen S, Myhre KI, Wisløff TF, Kristiansen IS.
    Scand Cardiovasc J; 2005 Oct 13; 39(5):276-85. PubMed ID: 16269397
    [Abstract] [Full Text] [Related]

  • 37. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP.
    Ann Intern Med; 2011 Jan 04; 154(1):1-11. PubMed ID: 21041570
    [Abstract] [Full Text] [Related]

  • 38. Cost-effectiveness of prehospital versus inhospital thrombolysis in acute myocardial infarction.
    Araújo DV, Tura BR, Brasileiro AL, Luz Neto H, Pavão AL, Teich V.
    Arq Bras Cardiol; 2008 Feb 04; 90(2):91-8. PubMed ID: 18392380
    [Abstract] [Full Text] [Related]

  • 39. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
    Kunz WG, Hunink MG, Sommer WH, Beyer SE, Meinel FG, Dorn F, Wirth S, Reiser MF, Ertl-Wagner B, Thierfelder KM.
    Stroke; 2016 Nov 04; 47(11):2797-2804. PubMed ID: 27758942
    [Abstract] [Full Text] [Related]

  • 40. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial.
    Chen J, Bhatt DL, Dunn ES, Shi C, Caro JJ, Mahoney EM, Gabriel S, Jackson JD, Topol EJ, Cohen DJ.
    Value Health; 2009 Sep 04; 12(6):872-9. PubMed ID: 19490556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.